SAS launches tool for Physician Targeting solution

14 April 2009

USA-based business analytics firm SAS has launched a new tool for physician targeting that helps organizations apply predictive analytics  to sales and idenitfy doctors based on profitability, retention and  future probability to prescribe.

The SAS for Physician Targeting solution can mine prescription data with  other information points, such as CRM data, managed care, health plan  and patient level data in order to predict which physicians are  responsible for the prescribing activity and segment accordingly. In  proof-of-value exercises, this approach has shown to increase the  precision of targeting between 18% to 26% compared to traditional top  decile targeting, the company notes.

In addition, the SAS OnDemand: Physician Targeting service provides the  same data on an as-needed basis. This service provides business  intelligence analytics on a shareable and scalable infrastructure tuned  specifically for the solution, the firm contends.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight